(For a Reuters live blog on U.S., UK and European stock markets, click (LIVE/) or type LIVE/ in a news window)
FTSE 100 down 0.2% and FTSE 250 up 0.1%
Standard Chartered CFO exit drags FTSE 100
BP drags after the oil giant suspends buybacks
AstraZeneca climbs on strong cancer drug outlook
Investors await U.S. jobs and inflation data for Fed rate clues
Feb 10 (Reuters) - The UK’s FTSE 100 slipped on Tuesday, dragged down by Standard Chartered after the Asia-focussed lender announced the departure of its CFO, while oil major BP slid after it suspended its share buyback programme.
The blue-chip FTSE 100 (.FTSE) fell 0.2% as of 1157 GMT, while the FTSE 250 midcap index (.FTMC) inched up 0.1%.
Standard Chartered (STAN.L) dropped 4.2%, among the top decliners in the blue-chip index, after the lender said Chief Financial Officer Diego De Giorgi had left the bank following a two-year stint.
BP (BP.L) sank 4% after it suspended its share buyback programme and took about $4 billion of charges in its renewables and biogas assets as the oil major reported quarterly profit that met expectations.
Investors were also focussed on political developments after British Prime Minister Keir Starmer refused to heed calls to quit, even by the leader of his party in Scotland, pledging to fight on after his appointment of Peter Mandelson as U.S. ambassador plunged his government into a crisis.
Under pressure over the appointment of a man whose close ties to the late U.S. sex offender Jeffrey Epstein have come into full focus, Starmer has attempted to change the narrative.
The sterling (GBP=D3) and UK government bond yields were calmer on Tuesday after days of sharp declines. British stocks have largely been driven by corporate earnings and the global mood.
Among other movers, AstraZeneca (AZN.L) rose 0.3% after the Anglo-Swedish drugmaker forecast steady growth in 2026 on strong cancer drug demand.
Barclays (BARC.L) increased its profit by 12% in 2025 and raised its performance targets as it looks to improve returns by cutting costs and improving income, especially in its U.S. business. The bank’s shares fell 1.6%.

HSBA

STAN

HMCX

MIDD

HUKX

L100

The UK's FTSE 100 index fell 0.2%, impacted by Standard Chartered's CFO departure and BP's suspension of its share buyback program, which caused a 4% drop in BP's shares. Meanwhile, AstraZeneca rose 0.3% on positive cancer drug forecasts. Investors are awaiting U.S. jobs and inflation data for insights on Federal Reserve rate decisions. The FTSE 250 index saw a slight increase of 0.1%.

London’s FTSE 100 dips as Standard Chartered, BP weigh